title: Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients.
authors.forename: A
authors.initials: A
authors.lastname: Mazumder
authors.forename: J
authors.initials: J
authors.lastname: Kaufman
authors.forename: R
authors.initials: R
authors.lastname: Niesvizky
authors.forename: S
authors.initials: S
authors.lastname: Lonial
authors.forename: D
authors.initials: D
authors.lastname: Vesole
authors.forename: S
authors.initials: S
authors.lastname: Jagannath
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D019650:Hematopoietic Stem Cell Mobilization; D006801:Humans; D000077269:Lenalidomide; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives; D016896:Treatment Outcome
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D013792:Thalidomide; D003520:Cyclophosphamide; D000077269:Lenalidomide